You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Empros Pharma presents positive topline results for EMP16
Text:
Kim Liedholm | [email protected]
Empros Pharma has reported positive topline results from the POEM clinical trial with the oral drug candidate EMP16. The treatment was well tolerated, confirming the candidate's potential as a safe and long-term therapy for weight management....